SCHEMBL8301100

SCHEMBL8301100

CCN1C(=O)c2cccnc2N(CC)c2ncccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
CASP1 P29466 3/20 0.50
HPGD P15428 1/20 0.50
MPI P34949 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
BRD4 O60885 3/20 0.48
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.44
APAF1 O14727 1/20 0.44
GAA P10253 1/20 0.44
THRB P10828 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP1B1 Q16678 2/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PKM P14618 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8791051 0.91 BRD4 (0.51) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL9369777 0.89 BRD4 (0.50) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL8299587 0.88 CYP3A4 (0.52) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL8298691 0.88 BRD4 (0.61) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL9370046 0.84 BRD4 (0.48) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL8791127 0.84 BRD4 (0.48) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL9369130 0.83 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL8101327 0.83 BRD4 (0.39) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL8791314 0.82 BRD4 (0.47) ALDH1A1SMN1; SMN2CASP1HPGDMPI
SCHEMBL4321443 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0393529-B1 5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1993-06-30 EP claimed
EP-0393529-A1 5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1990-10-24 EP claimed
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US disclosed
US-5366972-A 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1994-11-22 US disclosed
EP-0393529-B1 5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1993-06-30 EP disclosed
EP-0429987-A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-06-05 EP disclosed
EP-0393529-A1 5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1990-10-24 EP disclosed